Remove Events Remove Physicians Remove Safety Remove Side effects
article thumbnail

MHRA warns of serious eye-related adverse events after Dupixent use

Pharmaceutical Technology

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

article thumbnail

Is DTC effective?

World of DTC Marketing

How do physicians feel about patients asking for a new drug via a telehealth visit, and can the prescriber evaluate whether a patient is a good candidate or a new drug? When consumers stay at home amid broadly disruptive events, their media consumption rises nearly 60% — and even more in some cases, according to a Nielsen data analysis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

The week 16 data of lebrikizumab […] points towards a drug with robust efficacy with hardly any safety trade-offs. Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects. However, side effects do happen.

article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

These drugs have been rigorously tested by regulatory bodies around the world before they’re made available to ensure they work as labelled, but despite that, adverse events crop up. This means that hyper-metabolisers would need their dosage to be increased to achieve the desired effect. billion in the United States alone.

article thumbnail

New Study Demonstrates Consistent Positive Long-Term Adherence and Efficacy of Nerivio® for Treatment of Migraine

Legacy MEDSearch

Theranica , a neuromodulation therapeutics company, announced the publication of a comprehensive clinical study in Advances in Therapy examining the long-term utilization, clinical efficacy, and safety of Nerivio ® , a Remote Electrical Neuromodulation (REN) device for the treatment of migraine. As for clinical efficacy, 74.1%

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension. CareTrack Health.

article thumbnail

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

This blog post could provide information about the drug’s potential benefits, its side effects, and how it compares to other drugs on the market. For example, a pharmaceutical company could create a blog post about a new drug that it is developing.